Sanofi looks to widen Dupixent use to treat ‘smoker’s lung’ after second trial win

[ad_1] The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File photo Acquire Licensing Rights Nov 27 (Reuters) –…